2 / 9
allied
academies
Page 37
Notes:
Journal of Psychology and Cognition | Volume 4
May 13-14, 2019 | Prague, Czech Republic
Addiction Research and Therapy
2
nd
International Conference on
J Psychol Cognition, Volume 4
A retrospective chart review of Cranial Electrotherapy Stimulation for clients newly
admitted to Residential Drug Treatment
Charles A Fisher
Fisher Wallace Laboratories, USA
C
ranial electrotherapy stimulation (CES) has been shown
to produce improvements for insomnia, depression, and
anxiety among individuals afflicted with these conditions
bothwith andwithout primary substance abuse dependence.
This report presents findings from a retrospective chart
review examining the impact of CES on the retention
rates of newly abstinent substance dependent individuals
in community-based residential treatment. Clients who
received CES sessions during their first month in residential
treatment exhibited better retention rates during the first 30
days, as well as at 60 and 90 days in treatment, compared to
clients who did not receive CES. Sessions were well tolerated,
and clients reported improved sleep and reduced stress.
Speaker Biography
Charles A Fisher is a founder of Fisher Wallace Laboratories which is
working to improve the awareness of cranial electrotherapy stimulation
in the medical community and to reduce dependencies on medications.
A drug-free device available through prescription from any health
practitioner licensed for electrotherapy in the United States.
e:
chip@fisherwallace.com